Apollo outlines AMAPS as CLO allocation alternative, citing $25 billion outstanding across five deals

• Apollo outlined AMAPS as a rated, diversified vehicle positioned to replace insurer CLO allocations as CLO spreads compress.
• Five AMAPS structures total USD 25 billion outstanding, with Apollo projecting further growth.
• AMAPS targets about 40%-50% investment-grade collateral, about 9x debt-to-equity leverage, more than 1,000 obligors.
• Presentation compares blended IG spreads of S+212 bps for AMAPS versus S+136 bps for U.S. BSL CLOs.
• Athene is reducing CLO exposure, shifting allocations toward AMAPS, citing thicker equity at 10% versus 8% for U.S. BSL CLOs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apollo Global Management Inc. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.